Automated clinical solutions | Philips Healthcare

We understand that as the healthcare landscape continues to evolve, respiratory clinicians and care providers need a technology partner to help them deliver effective therapies and better care across the entire patient journey.

The automated clinical technologies* embedded in Philips Respironics ventilation solutions can help you to care for a wide range of unique patient needs, from critical to chronic, across the hospital and home.^1-5

Auto-Trak, AVAPS and AVAPS-AE are designed to deliver…

Customized care

Provides versatility for clinicians.
Provides customized ventilation to accommodate a wide range of patient needs.^1-3

Enhanced comfort

Offers comprehensive therapy to support patient comfort across the hospital and home settings.^1-6
Designed to maintain effective therapy to enhance patient comfort by adapting to their changing conditions.⁶

Simplified patient set up and management

Simplifies the complexity of managing ventilated patients.^1,7
Designed to address workflow challenges with automatic therapy adjustments.

Helping to improve patient outcomes and experiences

Even as a patient’s condition changes, our technologies automatically adjust the relevant features to deliver therapeutic comfort and care.

Learn more about how our technologies are designed to maintain effective therapy to enhance patient comfort by adapting to their changing conditions.⁶

More information, tools and resources are available on the Philips Learning Connection.

Visit now

Helping to simplify the complexities that care teams face when managing ventilated patients^1,7

Auto-Trak

Designed to automatically respond to changing breathing patterns and leaks to ensure optimal system response with every breath⁸:

Automatically helps to maintain optimal breath synchronization even in the presence of unintentional leaks.⁸
Decreases the need for frequent manual triggering and cycling adjustments, even in the presence of leaks, so that clinicians can focus on other aspects of patient care.

AVAPS

Designed to automatically adjust pressures to achieve the target tidal volume, minimizing the need for frequent bedside adjustments^9-11:

Helps to support patient comfort by providing the lowest pressure while ensuring a consistent tidal volume.^6,12
Provides consistent and reliable ventilation throughout changes in patient respiratory mechanics (compliance and resistance).
Automated Airway Management (AAM) is a customizable EPAP therapy that can be applied to Philips’ S, S/T, T, PC noninvasive pressure modes.**

It is designed to automatically and proactively titrate EPAP to reduce obstructive sleep events.**

AVAPS-AE

Designed to address common ventilation concerns, such as gas exchange, airway patency, and asynchrony¹³:

Helps to improve efficiency and shorten the time it takes to setup your noninvasive ventilation patients.⁷
As part of a multifaceted intervention program, has shown to reduce hospital readmissions.**¹⁴

How can respiratory care teams adopt these technologies?

Learn more about the devices that feature our automated clinical technologies.

DreamStation AVAPS

DreamStation BiPAP AVAPS algorithms provide appropriate therapeutic support to meet the changing needs of patients over time.^1,3,7,9

Learn more

Philips Respironics
Trilogy EV300

Delivers proven performance**** in noninvasive and invasive mechanical ventilation, so patients can be treated with a single device throughout their hospital stay, regardless of changing conditions.

Learn more

Philips Respironics
Trilogy Evo

A portable hospital-to-home ventilator that delivers non invasive and invasive ventilation, and is designed to stay with your patients across changing care environments.

Learn more

To learn more about our automated clinical technologies, please contact your Philips representative or complete the form below.

* Auto-Trak, AVAPS, AVAPS-AE.
** Not available in all markets or in Trilogy Evo Platform.
*** Study done with COPD patients

Murphy PB, Patout M, Arbane G, Mandal S, Kaltsakas G, Polkey MI, Elliott M, Muir JF, Douiri A, Parkin D, Janssens JP, Pépin JL, Cuvelier A, Flach C, Hart N. Cost-effectiveness of outpatient versus inpatient non-invasive ventilation setup in obesity hypoventilation syndrome: the OPIP trial. Thorax. 2023 Jan;78(1):24-31. doi: 10.1136/thorax-2021-218497. Epub 2022 Sep 2. PMID: 36342884.
Saddi V, Thambipillay G, Pithers S, Moody M, Martin B, Blecher G, Teng A. Average volume-assured pressure support vs conventional bilevel pressure support in pediatric nocturnal hypoventilation: a case series. J Clin Sleep Med. 2021 May 1;17(5):925-930. doi: 10.5664/jcsm.9084. PMID: 33393900; PMCID: PMC8320487.
Murphy PB, Arbane G, Ramsay M, Suh ES, Mandal S, Jayaram D, Leaver S, Polkey MI, Hart N. Safety and efficacy of auto-titrating noninvasive ventilation in COPD and obstructive sleep apnoea overlap syndrome. Eur Respir J. 2015 Aug;46(2):548-51. doi: 10.1183/09031936.00205714. Epub 2015 Jun 25. PMID: 26113686.
Maheshwari A, Khatri J, Soni G, et al. (December 05, 2022) Role of Average Volume Assured Pressure Support Mode (AVAPS) in the Management of Acute Exacerbation of Chronic Obstructive Pulmonary Disease With Type 2 Respiratory Failure. Cureus 14(12): e32200. DOI 10.7759/cureus.32200
Briones-Claudett KH, Briones-Claudett MH, Baños MDPC, Briones Zamora KH, Briones Marquez DC, Zimmermann LJI, Gavilanes AWD, Grunauer M. Noninvasive Mechanical Ventilation with Average Volume-Assured Pressure Support versus BiPAP S/T in De Novo Hypoxemic Respiratory Failure. Crit Care Res Pract. 2022 Aug 3;2022:4333345. doi: 10.1155/2022/4333345. PMID: 35966802; PMCID: PMC9365614.
Limsuwat, C., Rawangnam, W., Ruangsomboon, O., & Prapruetkit, N. (2019). Effect of non-invasive mechanical ventilation with average volume assured pressure support (AVAPS) in patients with chronic obstructive pulmonary disease with acute exacerbation: A randomized pilot trial. The Southwest Respiratory and Critical Care Chronicles, 7(30), 19-28. https://doi.org/10.12746/swrccc.v7i30.560
Patout M, Gagnadoux F, Rabec C, Trzepizur W, Georges M, Perrin C, Tamisier R, Pépin JL, Llontop C, Attali V, Goutorbe F, Pontier-Marchandise S, Cervantes P, Bironneau V, Portmann A, Delrieu J, Cuvelier A, Muir JF. AVAPS-AE versus ST mode: A randomized controlled trial in patients with obesity hypoventilation syndrome. Respirology. 2020 Oct;25(10):1073-1081. doi: 10.1111/resp.13784. Epub 2020 Feb 13. PMID: 32052923.
Yarascavitch J, (2022) Bench study: Philips Respironics Trilogy EV300 and V60/V60 Plus for noninvasive ventilation
Storre JH, Seuthe B, Fiechter R, Milioglou S, Dreher M, Sorichter S, Windisch W. Average volume-assured pressure support in obesity hypoventilation: A randomized crossover trial. Chest. 2006 Sep;130(3):815-21. doi: 10.1378/chest.130.3.815. PMID: 16963680.
Janssens JP, Metzger M, Sforza E. Impact of volume targeting on efficacy of bi-level non-invasive ventilation and sleep in obesity-hypoventilation. Respir Med. 2009 Feb;103(2):165-72. doi: 10.1016/j.rmed.2008.03.013. Epub 2008 Jun 24. PMID: 18579368.
Murphy PB, Davidson C, Hind MD, Simonds A, Williams AJ, Hopkinson NS, Moxham J, Polkey M, Hart N. Volume targeted versus pressure support non-invasive ventilation in patients with super obesity and chronic respiratory failure: a randomised controlled trial. Thorax. 2012 Aug;67(8):727-34. doi: 10.1136/thoraxjnl-2011-201081. Epub 2012 Mar 1. PMID: 22382596.
Cammarota G, Simonte R, De Robertis E. Comfort During Non-invasive Ventilation. Front Med (Lausanne). 2022 Mar 24;9:874250. doi: 10.3389/fmed.2022.874250. Erratum in: Front Med (Lausanne). 2023 Apr 04;10:1193466. doi: 10.3389/fmed.2023.1193466. PMID: 35402465; PMCID: PMC8988041.
Ramsay M, Mandal S, Suh ES, Steier J, Douiri A, Murphy PB, Polkey M, Simonds A, Hart N. Parasternal electromyography to determine the relationship between patient-ventilator asynchrony and nocturnal gas exchange during home mechanical ventilation set-up. Thorax. 2015 Oct;70(10):946-52. doi: 10.1136/thoraxjnl-2015-206944. Epub 2015 Jul 21. PMID: 26197816.
Coughlin S, Peyerl FW, Munson SH, Ravindranath AJ, Lee-Chiong TL. Cost Savings from Reduced Hospitalizations with Use of Home Noninvasive Ventilation for COPD. Value Health. 2017 Mar;20(3):379-387. doi: 10.1016/j.jval.2016.09.2401. Epub 2016 Nov 11. PMID: 28292482.

Last update: August 2024

Philips Respironics ventilation solutions

Automated clinical technologies

Auto-Trak, AVAPS and AVAPS-AE are designed to deliver…

Customized care

Enhanced comfort

Simplified patient set up and management

Helping to improve patient outcomes and experiences

Helping to simplify the complexities that care teams face when managing ventilated patients1,7

Auto-Trak

Designed to automatically respond to changing breathing patterns and leaks to ensure optimal system response with every breath8:

AVAPS

Designed to automatically adjust pressures to achieve the target tidal volume, minimizing the need for frequent bedside adjustments9-11:

AVAPS-AE

Designed to address common ventilation concerns, such as gas exchange, airway patency, and asynchrony13:

How can respiratory care teams adopt these technologies?

Learn more about the devices that feature our automated clinical technologies.

DreamStation AVAPS

Philips Respironics Trilogy EV300

Philips Respironics Trilogy Evo

To learn more about our automated clinical technologies, please contact your Philips representative or complete the form below.

Helping to simplify the complexities that care teams face when managing ventilated patients^1,7

Designed to automatically respond to changing breathing patterns and leaks to ensure optimal system response with every breath⁸:

Designed to automatically adjust pressures to achieve the target tidal volume, minimizing the need for frequent bedside adjustments^9-11:

Designed to address common ventilation concerns, such as gas exchange, airway patency, and asynchrony¹³:

Philips Respironics
Trilogy EV300

Philips Respironics
Trilogy Evo